Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Adenosine triphosphate (ATP), also known as ATP, is a molecule that carries energy within cells. It is one of the most important biological compounds because of its role in supplying energy for life. ATP is the universal energy carrier used by all organisms to supply energy for biological functions. It is often referred to as the energy currency of cells. ATP also functions as a neurotransmitter that is stored and secreted with other neurotransmitters from the pancreas. ATP is a nucleotide consisting of the nucleoside adenosine with three attached phosphate groups (see Adenine). Like other nucleotides, ATP consists of three parts: a sugar, an amine base, and a phosphate group. The central part of the molecule in ATP is the sugar ribose. The amine base adenine is attached to the ribose, forming adenosine. Opposite the adenine on the ribose is attached a chain of three phosphate groups.

56-65-5

Post Buying Request

56-65-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

56-65-5 Usage

Uses

Used in Cellular Energy Processes:
Adenosine triphosphate is used as an energy source for various cellular processes, as it is the primary molecule for energy transfer and storage within cells. The conversion from ATP to ADP (adenosine diphosphate) releases energy that can be utilized by the cell for various functions.
Used in Active Transport Mechanisms:
Adenosine triphosphate is used as an energy provider for active transport mechanisms, which are responsible for the transport of macromolecules such as proteins and lipids into and out of the cell. The hydrolysis of ATP provides the required energy for these active transport mechanisms to carry such molecules across a concentration gradient.
Used in Agricultural Applications:
Adenosine triphosphate is used as a carrier of chemical energy in all living organisms, including plants. It plays a fundamental role in the plant system for energy storage and transfer. During biochemical processes, ATP is synthesized to store releasable energy, and the breakdown of ATP to ADP (adenosine diphosphate) and phosphate ion by dephosphorylation allows ADP and ATP to act as energy currency within the plant.

Originator

Atepodin ,Medix ,Spain

History

ATP was first isolated by the German chemist Karl Lohmann (1898–1978) from muscle tissue extracts in 1929. Alexander Todd’s (1907–1997) research helped to clarify ATP’s structure, and it was first synthesized by Todd in 1948.

Synthesis

ATP is synthesized in organisms by several related mechanisms. Oxidative phosphorylation is the main process that aerobic organisms use to produce ATP. Oxidative phosphorylation produces ATP from ADP and inorganic phosphate (Pi) from the oxidation of nicotinamide adenine dinucleotide (NADH) by molecular oxygen in the cell’s mitochondria. Glycolysis is another process that generates ATP. Glycolysis converts glucose into pyruvate and in the process also forms NADH and ATP. The process can be represented as: Glucose + 2ADP + 2NAD+ + 2Pi → 2 pyruvate + 2ATP + 2NADH + 2H+. In this reaction Pi represents free inorganic phosphate. The rate of glycolysis in the body is inversely related to the amount of available ATP. Pyruvate produced by glycolysis can enter the Krebs cycle, producing more ATP.

Manufacturing Process

With a solution of 0.29 part by weight of well dried 1,3- dicyclohexylguanidinium adenosine 5'-phosphoramidate in 5 parts by volume of ortho-chlorophenol is admixed a solution of 0.95 part by weight of bistriethylammonium pyrophosphate in a mixed solvent composed of 1 part by volume of ortho-chlorophenol and 2 parts by volume of acetonitrile. The mixture is left standing at 20°C for 2 days. Then 30 parts by volume of water is added to the mixture. After washing with three 15 parts by weight volumeportions of diethyl ether, the aqueous layer is separated, and the remaining diethyl ether in the aqueous layer is removed under reduced pressure. Five parts by weight of activated charcoal is added to the aqueous layer and the mixture is stirred for 30 minutes. The activated charcoal is filtered and further 1 part by weight of activated charcoal is added to the filtrate. After 20 minutes agitation, the activated charcoal is taken out by filtration. The combined activated charcoal is washed with a little water, and eluted twice with respective 300 and 200 parts by volume-portions of 50% (volume) ethanol containing 2% (volume) of concentrated aqueous ammonia. The eluate is concentrated to 40 parts by volume, then is passed through a column packed with 20 parts by volume of a strongly basic anion exchange resin in bead form (chloric type) (polystyrene trimethylbenzyl ammonium type resin sold under the name of Dowex-1 from Dow Chemical Company, Mich. USA). Then, the column is washed with 750 parts by volume of an acid aqueous saline solution containing 0.01 normal hydrochloric acid and 0.02 normal sodium chloride and then eluted with 600 parts by volume of an acid aqueous saline solution composed of 0.01 normal hydrochloric acid and 0.2 normal sodium chloride. After neutralizing with a diluted sodium hydroxide solution, the eluate is treated with activated charcoal to adsorb ATP as its sodium salt. The separated activated charcoal is washed with water and eluted with 60% (volume) ethanol containing 2% (volume) of concentrated aqueous ammonia. The eluate is concentrated to 0.5 part by volume, then 5 parts by volume of ethanol is added. The precipitate thus deposited is centrifuged and dried at low temperature to obtain 0.155 part by weight of tetra-sodium salt of ATP containing 4 mols of water of crystallization as a colorless crystalline powder. The yield is 47% relative to the theoretical.

Therapeutic Function

Coenzyme, Vasodilator

Safety Profile

Poison by intraperitoneal route.Human mutation data reported. When heated todecomposition it emits toxic fumes of POx and NOx.

Purification Methods

ATP is purified by precipitating it as the barium salt on adding excess barium acetate solution to a 5% solution of ATP in water. The precipitate is filtered off, washed with distilled water, dissolved in 0.2M HNO3 and again precipitated with barium acetate. The precipitate, after several washings with distilled water, is redissolved in 0.2M HNO3, and slightly more than an equivalent of 0.2M H2SO4 is added to precipitate all the barium as BaSO4 which is filtered off. The ATP is then precipitated by addition of a large excess of 95% ethanol. It is filtered off, washed several times with 100% EtOH and finally with dry diethyl ether. It is dried in vacuo. [Kashiwagi & Rabinovitch J Phys Chem 59 498 1955, Beilstein 26 III/IV 3654.]

Check Digit Verification of cas no

The CAS Registry Mumber 56-65-5 includes 5 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 2 digits, 5 and 6 respectively; the second part has 2 digits, 6 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 56-65:
(4*5)+(3*6)+(2*6)+(1*5)=55
55 % 10 = 5
So 56-65-5 is a valid CAS Registry Number.

56-65-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name ATP

1.2 Other means of identification

Product number -
Other names atipi

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:56-65-5 SDS

56-65-5Synthetic route

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

A

adenosine-5'-O-(3-thiotriphosphate)
35094-46-3

adenosine-5'-O-(3-thiotriphosphate)

B

ATP
56-65-5

ATP

C

phosphate

phosphate

Conditions
ConditionsYield
With dihydroxyacetone phosphate; ethylenediaminetetraacetic acid; DL-dithiothreitol; NAD; trisodium thiophosphate; 2-oxo-propionic acid; magnesium chloride; phosphoglycerate kinase; immobil. triosephosphate isomerase; glyceraldehyde-3-phosphate dehydrogenase; lactate dehydrogenase In water for 72h; Ambient temperature; 1) pH 7.5;A 80%
B n/a
C n/a
5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
With tetrakis(tetra-n-butylammonium) hydrogen triphosphate In acetonitrile for 48h; Ambient temperature;72%
5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

A

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

B

ATP
56-65-5

ATP

C

adenosine 5'-tetraphosphate
1062-98-2

adenosine 5'-tetraphosphate

Conditions
ConditionsYield
With manganese(ll) chloride; tri-1-benzimidazolylphosphine oxide at 50℃; for 72h; N-ethylmorpholine buffer (pH 7.0);A 65%
B 17%
C 3%
With magnesium chloride; tri-1-benzimidazolylphosphine oxide at 50℃; for 72h; N-ethylmorpholine buffer (pH 7.0);A 26%
B 36%
C 18%
adenosine 5'-<α-thio>triphosphate
29220-54-0

adenosine 5'-<α-thio>triphosphate

Conditions
ConditionsYield
With dihydrogen peroxide65%
tetrakis(tetra-n-butylammonium) hydrogen triphosphate
93978-77-9

tetrakis(tetra-n-butylammonium) hydrogen triphosphate

5'-tosyladenosine
5135-30-8

5'-tosyladenosine

Conditions
ConditionsYield
In acetonitrile for 23h;55%
5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

A

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With phosphorotriimidazolide; magnesium chloride at 22℃; for 168h; N-ethylmorpholine buffer (pH 7.0);A 25%
B 43%
With 2,3,6-trimethyl-beta-cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00;
With magnesium; β‐cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00;
Morpholin-4-yl-phosphonic acid mono-{(3aR,4R,6R,6aR)-2-methoxy-6-[6-(4-methoxy-phenylamino)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl} ester

Morpholin-4-yl-phosphonic acid mono-{(3aR,4R,6R,6aR)-2-methoxy-6-[6-(4-methoxy-phenylamino)-purin-9-yl]-tetrahydro-furo[3,4-d][1,3]dioxol-4-ylmethyl} ester

Conditions
ConditionsYield
With bis(tri-n-butylammonium) pyrophosphate In N,N-dimethyl-formamide42%
fructose-1,6-bisphosphate
488-69-7

fructose-1,6-bisphosphate

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With yeast-maceration juice
Phosphocreatine
67-07-2

Phosphocreatine

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With creatine-kinase beim Behandeln mit einem Enzym-Praeparat aus Escherichia coli;
5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With Tri-n-octylamine; phosphoric acid; cyclopentanone-[O-(4-nitro-benzenesulfonyl)-oxime ]; N,N-dimethyl-formamide
With pyridine; phosphoric acid; water; dicyclohexyl-carbodiimide Reagens 4: Tributylamin;
With 5-phosphoribosyl 1-pyrophosphate synthetase; 5-phosphoribosyl 1-pyrophosphate Enzyme kinetics;
adenosine
58-61-7

adenosine

A

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With phosphoric acid; brewer's yeast-substance; water
With D-glucose; phosphoric acid; brewer's yeast-substance; water
With fructose-1,6-bisphosphate; phosphoric acid; brewer's yeast-substance; water
adenosine 5'-triphosphate γ(1-[2-nitrophenyl]ethyl) ester
67030-27-7

adenosine 5'-triphosphate γ(1-[2-nitrophenyl]ethyl) ester

A

ortho-nitroso acetophenone
25798-61-2

ortho-nitroso acetophenone

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid; potassium chloride; magnesium chloride at 21℃; Mechanism; Quantum yield; Rate constant; Irradiation; pH 7.1;
With brucine buffer In water at 10℃; Product distribution; Irradiation; other reagent;
phosphocreatine
4087-38-1

phosphocreatine

Conditions
ConditionsYield
With creatine kinease Rate constant;
Adenosine 5'<(S)α-thio>triphosphate
58976-48-0

Adenosine 5'<(S)α-thio>triphosphate

Conditions
ConditionsYield
With bromine In water for 0.0666667h; Ambient temperature;
5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

A

5'-inosine monophosphate
131-99-7

5'-inosine monophosphate

B

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

C

ATP
56-65-5

ATP

Conditions
ConditionsYield
With zinc(II) chloride In methanol at 25℃; Product distribution; biosynthesis; various typ-, and conc. of reagent;
In methanol at 25℃; biosynthesis by Candida boidnii No. 2201; pH = 6.5;A 14.8 mmol
B 36.8 mmol
C 24.0 mmol
With zinc(II) chloride In methanol at 25℃; biosynthesis by Candida boidnii No. 2201; pH = 6.5;A 2.0 mmol
B n/a
C 36.8 mmol
In methanol at 25℃; biosynthesis by Candida boidnii No. 2201; pH = 6.5;A 14.8 mmol
B 1.1 mmol
C 24.0 mmol
ethyl ester of adenosine 5'-triiphospho-(Pγ-> N)-alanine
113693-26-8

ethyl ester of adenosine 5'-triiphospho-(Pγ-> N)-alanine

A

L-Alanine ethyl ester
3082-75-5

L-Alanine ethyl ester

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With hydrogenchloride at 37℃; for 1h; Product distribution;
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

A

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With heptakis(2,6-di-O-methyl)cyclomaltoheptaose; magnesium chloride In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00, ATP formation in presence and absence of DM-β-CD;
With magnesium; β‐cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00;
With 2,3,6-trimethyl-beta-cyclodextrin In water at 37℃; Product distribution; equilibrium constant phosphate buffer, pH 7.00;
With adenylate kinase; magnesium sulfate In water at 36.9℃; Rate constant;
With tobacco chloroplast adenylate kinase; magnesium sulfate Enzyme kinetics; transphosphorylation;
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

Conditions
ConditionsYield
With acetylphosphoric acid; magnesium(II); 1,13-Dioxa-4,7,10,16,19,22-hexaazacyclotetracosane In water at 40℃; Product distribution; Mechanism; also in the absence of metal cation; other solvents;
With acetic acid phosphoric acid-anhydride; iron(III) sulfate at 30℃; var. metal salts;
With aminacrine; phosphoric acid; N-tris(hydroxymethyl) methylglycine; chloroplasts from spinach; potassium chloride; 1,1'-dibenzyl-4,4'-bipyridinium; phenazine methosulfate; magnesium chloride; ascorbic acid at 20℃; for 0.0166667h; Kinetics; Mechanism; Irradiation; var. of H+ conc.;
C19H19ClN6O10P2
170638-51-4

C19H19ClN6O10P2

Conditions
ConditionsYield
With phosphoric acid; copper dichloride for 24h; Ambient temperature; Yield given;
C18H23N6O15P3

C18H23N6O15P3

A

ortho-nitroso acetophenone
25798-61-2

ortho-nitroso acetophenone

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
With potassium hydroxide; N-(2-acetamido)-3-iminodiacetic acid at 22℃; Rate constant; Irradiation;
adenosine
58-61-7

adenosine

Conditions
ConditionsYield
With human deoxycytidine kinase; ATP; magnesium chloride In water at 37℃; pH=7.5; Enzyme kinetics; phosphorylation;
Multistep reaction;
C20H26N6*C10H16N5O13P3

C20H26N6*C10H16N5O13P3

A

ATP
56-65-5

ATP

B

2,5,8,11-tetraaza<12>-<12>(2,9)<1,10>-phenanthrolinophane
221350-58-9

2,5,8,11-tetraaza<12>-<12>(2,9)<1,10>-phenanthrolinophane

Conditions
ConditionsYield
With tetramethlyammonium chloride In water at 24.95℃; pH=2.5 - 11; Equilibrium constant; decomplexation;
C23H32N6*C10H16N5O13P3

C23H32N6*C10H16N5O13P3

A

ATP
56-65-5

ATP

B

2,6,10,14-tetraaza[15](2,9)cyclo(1,10)phenanthrolinophane
246247-12-1

2,6,10,14-tetraaza[15](2,9)cyclo(1,10)phenanthrolinophane

Conditions
ConditionsYield
With tetramethlyammonium chloride In water at 24.95℃; pH=2.5 - 11; Equilibrium constant; decomplexation;
C48H72N4O4(4+)*C10H16N5O13P3*4Cl(1-)

C48H72N4O4(4+)*C10H16N5O13P3*4Cl(1-)

A

5,11,17,23-tetramethoxy-25,26,27,28-tetrakis(trimethylammoniomethyl)calix<4>arene tetrachloride
139934-97-7

5,11,17,23-tetramethoxy-25,26,27,28-tetrakis(trimethylammoniomethyl)calix<4>arene tetrachloride

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
C56H88N4O4(4+)*C10H16N5O13P3*4Cl(1-)

C56H88N4O4(4+)*C10H16N5O13P3*4Cl(1-)

A

5,11,17,23-tetrakis(trimethylammoniomethyl)-25,26,27,28-tetrapropoxycalix<4>arene tetrachloride

5,11,17,23-tetrakis(trimethylammoniomethyl)-25,26,27,28-tetrapropoxycalix<4>arene tetrachloride

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
C72H108N6O6(6+)*C10H16N5O13P3*6Cl(1-)

C72H108N6O6(6+)*C10H16N5O13P3*6Cl(1-)

A

5,11,17,23,29,35-hexakis-37,38,39,40,41,42-hexamethoxycalix<6>arene

5,11,17,23,29,35-hexakis-37,38,39,40,41,42-hexamethoxycalix<6>arene

B

ATP
56-65-5

ATP

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
C96H144N8O8(8+)*C10H16N5O13P3*8Cl(1-)

C96H144N8O8(8+)*C10H16N5O13P3*8Cl(1-)

A

ATP
56-65-5

ATP

B

49,50,51,52,53,54,55,56-octamethoxy-5,11,17,23,29,35,41,47-octakis(trimethylammoniomethyl)calix[8]arene octachloride

49,50,51,52,53,54,55,56-octamethoxy-5,11,17,23,29,35,41,47-octakis(trimethylammoniomethyl)calix[8]arene octachloride

Conditions
ConditionsYield
In water-d2 at 24.85℃; Equilibrium constant; Thermodynamic data; decomplexation;
dibenzyl phosphochloridate
538-37-4

dibenzyl phosphochloridate

disilver-salt of/the/ <5'>adenylic acid

disilver-salt of/the/ <5'>adenylic acid

Conditions
ConditionsYield
With acetonitrile; phenol beim anschliessenden Hydrieren an Palladium in wss. Dioxan;
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

polymer metaphosphate

polymer metaphosphate

poly phosphate-kinase

poly phosphate-kinase

Conditions
ConditionsYield
reversible Phosphorylierung;
L-methionine
63-68-3

L-methionine

(S)-(S)-adenosyl-L-methionine

(S)-(S)-adenosyl-L-methionine

Conditions
ConditionsYield
With Tris-HCl buffer; ethylenediaminetetraacetic acid; Escherichia coli S-adenosyl-L-methionine synthetase; potassium chloride; 2-hydroxyethanethiol; magnesium chloride In water for 5h; Ambient temperature;100%
adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

Conditions
ConditionsYield
With Dehydracetic acid; immobilized Glycerokinase for 2h; Ambient temperature;98%
With hydrogenchloride
With manganese(II) sulfate; phosphoric acid
Diadenosine tetraphosphate
5542-28-9

Diadenosine tetraphosphate

Conditions
ConditionsYield
With LEUCINE In various solvent(s) at 40℃; at pH 7.5; ATP-regenerating system of acetate kinase, adenylate kinase, PPase with acetyl phosphate;98%
With LEUCINE In various solvent(s) at 40℃; Product distribution; effect of different di- and tri-charged cations on Ap4A synthesis;
With L-lysine; lysyl tRNA synthetase (LysU); TRIS buffer pH 8; potassium chloride; magnesium chloride; zinc(II) chloride at 37℃; Rate constant; various temp, pH, various metal chloride;
Multi-step reaction with 2 steps
1: ZnCl2, MgCl2, KCl, TRIS buffer pH 8 / 2.5 h / 37 °C / lysyl tRNA synthetase (LysU), inorganic pyrophosphatase
2: ZnCl2, MgCl2, KCl, TRIS buffer pH 8, L-lysine / 37 °C / lysyl tRNA synthetase (LisU), inorganic pyrophosphatase
View Scheme
1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)nicotinamide-5'-phosphate
133473-75-3

1-(2'-deoxy-2'-fluoro-β-D-arabinofuranosyl)nicotinamide-5'-phosphate

2'-deoxy-2'-fluoroarabino-NAD+
133575-27-6

2'-deoxy-2'-fluoroarabino-NAD+

Conditions
ConditionsYield
With pyrophosphatase; magnesium chloride In water at 37℃; for 1h; pH=Ca. 7.4; aq. phosphate buffer; Enzymatic reaction;95%
[10a-13C1]riboflavin

[10a-13C1]riboflavin

C26(13)CH33N9O15P2

C26(13)CH33N9O15P2

Conditions
ConditionsYield
With rabbit muscle pyruvate kinase; baker's yeast inorganic pyrophosphatase; Corynebacterium ammoniagenes recombinant flavokinase/FAD synthetase In aq. buffer at 37℃; for 12h; pH=8; Enzymatic reaction;95%
β-2'-deoxy-2'-fluororibonicotinamide mononucleotide
1173700-41-8

β-2'-deoxy-2'-fluororibonicotinamide mononucleotide

2'-deoxy-2'-fluororibo-NAD+
159993-17-6

2'-deoxy-2'-fluororibo-NAD+

Conditions
ConditionsYield
With pyrophosphatase; magnesium chloride In water at 37℃; for 1h; pH=Ca. 7.4; aq. phosphate buffer; Enzymatic reaction;94%
β-2'-deoxy-2',2'-difluororibonicotinamide mononucleotide
1173700-38-3

β-2'-deoxy-2',2'-difluororibonicotinamide mononucleotide

2'-deoxy-2',2'-difluoro-NAD+
1260238-56-9

2'-deoxy-2',2'-difluoro-NAD+

Conditions
ConditionsYield
With pyrophosphatase; magnesium chloride In water at 37℃; for 1h; pH=Ca. 7.4; aq. phosphate buffer; Enzymatic reaction;90%
With magnesium chloride; pyrophosphatase; yeast nicotinamide mononucleotide adenylyltransferase 1 at 37℃; for 1h; pH=~ 7.4; Aqueous phosphate buffer; Enzymatic reaction;
[8a-13C1]-6,7-dimethyl-8-ribityllumazine

[8a-13C1]-6,7-dimethyl-8-ribityllumazine

3,4-dihydroxy-2-butanone 4-phosphate
114155-98-5

3,4-dihydroxy-2-butanone 4-phosphate

C26(13)CH33N9O15P2

C26(13)CH33N9O15P2

Conditions
ConditionsYield
With rabbit muscle pyruvate kinase; Bacillus subtilis recombinant lumazine synthase; Corynebacterium ammoniagenes recombinant flavokinase/FAD synthetase; Escherichia coli recombinant riboflavin synthase In aq. buffer at 37℃; for 12h; pH=7.6;90%
Conditions
ConditionsYield
With DL-dithiothreitol; L. leichmannii ribonucleosidetriphosphate reductase In various solvent(s) at 25℃; for 120h; Reduction; Enzymatic reaction;89%
With ribonucleoside triphosphate reductase; 5'-deoxyadenosylcobalamine; NADPH at 37℃; Kinetics; Reduction;
L-2H3>methionine
13010-53-2

L-2H3>methionine

S-adenosyl-L-[methyl-2H3]methionine
68684-40-2

S-adenosyl-L-[methyl-2H3]methionine

Conditions
ConditionsYield
With pyrophosphatase; ethylenediaminetetraacetic acid; AdoMet synthetase lysate; tris hydrochloride; 2-hydroxyethanethiol at 25℃; pH=8.0;87.9%
With SAM synthetase overexpressed by E. coli strain DM22-(pK8); magnesium chloride In acetonitrile at 20℃; for 5h; pH=8; Enzymatic reaction;
C12H17FO8

C12H17FO8

guanosine 5'-diphosphono-6-fluoro-β-L-fucopyranoside

guanosine 5'-diphosphono-6-fluoro-β-L-fucopyranoside

Conditions
ConditionsYield
Stage #1: C12H17FO8 With sodium methylate In methanol at 20℃; for 2h;
Stage #2: ATP With L-fucokinase/GDP-fucose pyrophosphorylase; magnesium chloride; manganese(ll) chloride at 37℃; pH=7.5; Enzymatic reaction;
87%
[methyl-13C]-L-methionine
49705-26-2

[methyl-13C]-L-methionine

[S-13C-methyl]adenosyl-L-methionine

[S-13C-methyl]adenosyl-L-methionine

Conditions
ConditionsYield
With pyrophosphatase; ethylenediaminetetraacetic acid; AdoMet synthetase lysate; tris hydrochloride; 2-hydroxyethanethiol at 25℃; pH=8.0;86%
With recombinant Methanococcus jannaschii AdoMet synthetase at 24.84℃; for 5h; Enzymatic reaction;
With methionine adenosyltransferase from Sulfolobus solfataricus In aq. phosphate buffer at 37℃; for 1h; pH=8; Enzymatic reaction;
adenosine 5'-tetraphosphate
1062-98-2

adenosine 5'-tetraphosphate

Conditions
ConditionsYield
With LEUCINE In various solvent(s) at 40℃; at pH 7.5; ATP-regenerating system of acetate kinase, adenylate kinase, PPase with acetyl phosphate;84%
With pyrophosphatase; L-lysine; tripolyphosphate; potassium chloride; magnesium chloride In water at 37℃; for 2h; pH 8;52%
Multi-step reaction with 2 steps
1: ZnCl2, MgCl2, KCl, TRIS buffer pH 8 / 2.5 h / 37 °C / lysyl tRNA synthetase (LysU), inorganic pyrophosphatase
2: 52 percent / sodium tripolyphosphate, ZnCl2 / 37 °C
View Scheme
adenosine 5'-tetraphosphate
1062-98-2

adenosine 5'-tetraphosphate

p1,p5-di(adenosine 5'-)pentaphosphate
41708-91-2

p1,p5-di(adenosine 5'-)pentaphosphate

Conditions
ConditionsYield
With LEUCINE In various solvent(s) at 40℃; at pH 7.5; ATP-regenerating system of acetate kinase, adenylate kinase, PPase with acetyl phosphate;80%
C27H45N10O15P3S

C27H45N10O15P3S

C37H57N15O21P4S

C37H57N15O21P4S

Conditions
ConditionsYield
With L-lysine; tris hydrochloride; magnesium chloride; zinc(II) chloride at 37℃; for 0.666667h; pH=8; Enzymatic reaction;80%
C26H43N10O16P3S

C26H43N10O16P3S

C36H55N15O22P4S

C36H55N15O22P4S

Conditions
ConditionsYield
With L-lysine; tris hydrochloride; magnesium chloride; zinc(II) chloride at 37℃; for 0.666667h; pH=8; Enzymatic reaction;80%
(3S,4R,5R,6S)-3-fluoro-6-methyl-tetrahydro-2H-pyran-2,4,5-triyl triacetate
188783-78-0

(3S,4R,5R,6S)-3-fluoro-6-methyl-tetrahydro-2H-pyran-2,4,5-triyl triacetate

guanosine 5'-diphospho-2-deoxy-2-fluoro-β-L-fucopyranoside

guanosine 5'-diphospho-2-deoxy-2-fluoro-β-L-fucopyranoside

Conditions
ConditionsYield
Stage #1: (3S,4R,5R,6S)-3-fluoro-6-methyl-tetrahydro-2H-pyran-2,4,5-triyl triacetate With sodium methylate In methanol at 20℃; for 2h;
Stage #2: ATP With L-fucokinase/GDP-fucose pyrophosphorylase; magnesium chloride; manganese(ll) chloride at 37℃; pH=7.5; Enzymatic reaction;
80%
α-D-glucopyranosyl-1-phosphate
59-56-3

α-D-glucopyranosyl-1-phosphate

adenosine-5'-(α-D-glucopyranosyl)diphosphate
2140-58-1

adenosine-5'-(α-D-glucopyranosyl)diphosphate

Conditions
ConditionsYield
With Glucose-1-phosphate thymidylyltransferase from Streptococcus pneumonia serotype 23F; magnesium chloride at 37℃; for 6h; Enzymatic reaction;78%
With Tris-HCl buffer; A. thermoaerophilus DSM 10155 RmlA3 thymidylyltransferase; magnesium chloride; inorganic pyrophosphatase at 37℃; for 24h;
C19H28N2O6

C19H28N2O6

C29H42N7O18P3

C29H42N7O18P3

Conditions
ConditionsYield
With pantothenate kinase; dephosphocoenzyme A kinase; phosphopantetheine adenyltransferase; potassium chloride; magnesium chloride In aq. buffer pH=8; Enzymatic reaction;77%
adenosine 5'-phosphorimidazolide
20816-58-4, 116273-87-1

adenosine 5'-phosphorimidazolide

Diadenosine tetraphosphate
5542-28-9

Diadenosine tetraphosphate

Conditions
ConditionsYield
With H96F-Fhit; magnesium chloride In various solvent(s) at 20℃; for 1h; pH=5.5;75%
23,24-Bisnorchola-1,4-dien-3-one-22-carboxylic acid
3614-61-7, 5327-60-6, 66512-12-7, 96686-97-4, 14508-05-5

23,24-Bisnorchola-1,4-dien-3-one-22-carboxylic acid

coenzyme A
85-61-0

coenzyme A

A

3-oxo-23,24-bisnorchol-4-en-22-oyl-coenzyme A
1380518-01-3

3-oxo-23,24-bisnorchol-4-en-22-oyl-coenzyme A

B

5'-adenosine monophosphate
61-19-8

5'-adenosine monophosphate

Conditions
ConditionsYield
With recombinant Rhodococcus jostii RHA1 CasI; magnesium chloride In ethanol at 22℃; for 7h; pH=7.5; aq. buffer; Enzymatic reaction;A 75%
B n/a
C12H15F3O8

C12H15F3O8

GDP-6,6,6-trifluorofucose

GDP-6,6,6-trifluorofucose

Conditions
ConditionsYield
Stage #1: C12H15F3O8 With sodium methylate In methanol at 20℃; for 2h;
Stage #2: ATP With L-fucokinase/GDP-fucose pyrophosphorylase; magnesium chloride; manganese(ll) chloride at 37℃; pH=7.5; Enzymatic reaction;
75%
5'-XTP
6253-56-1

5'-XTP

adenosine(xanthosine) 5',5'''-P1,P4-tetraphosphate

adenosine(xanthosine) 5',5'''-P1,P4-tetraphosphate

Conditions
ConditionsYield
With pyrophosphatase; L-lysine; potassium chloride; magnesium chloride In water at 37℃; for 2h; pH 8;74%
With L-lysine; TRIS buffer pH 8; potassium chloride; magnesium chloride; zinc(II) chloride at 37℃; for 24h; lysyl tRNA synthetase (LisU), inorganic pyrophosphatase;66%

A

adenosine 5'-diphosphate
58-64-0

adenosine 5'-diphosphate

B

PAPS
482-67-7

PAPS

Conditions
ConditionsYield
With phospho(enol)pyruvate; potassium chloride; sodium sulfate; magnesium chloride for 8h; Ambient temperature; tris-HCl buffer pH 8.0, ATP sulfurylase, APS kinase, pyruvate kinase, inorganic pyrophosphatase;A n/a
B 73%
adenosine(2'-deoxythymidyne) 5',5'''-P1,P4-tetraphosphate

adenosine(2'-deoxythymidyne) 5',5'''-P1,P4-tetraphosphate

Conditions
ConditionsYield
With L-lysine; TRIS buffer pH 8; potassium chloride; magnesium chloride; zinc(II) chloride at 37℃; for 24h; lysyl tRNA synthetase (LisU), inorganic pyrophosphatase;73%
C11H23N3O4
943528-71-0

C11H23N3O4

amino-coenzyme A
943528-72-1

amino-coenzyme A

Conditions
ConditionsYield
With DPCK; PanK; PPAT; potassium chloride; magnesium chloride for 1.5h; pH=9; aq. Tris/HCl; Enzymatic reaction;72%
C12H16F2O8

C12H16F2O8

C16H23F2N5O15P2

C16H23F2N5O15P2

Conditions
ConditionsYield
Stage #1: C12H16F2O8 With sodium methylate In methanol at 20℃; for 2h;
Stage #2: ATP With L-fucokinase/GDP-fucose pyrophosphorylase; magnesium chloride; manganese(ll) chloride at 37℃; pH=7.5; Enzymatic reaction;
72%
Inosine 5'-triphosphate
132-06-9

Inosine 5'-triphosphate

adenosine(inosine) 5',5'''-P1,P4-tetraphosphate

adenosine(inosine) 5',5'''-P1,P4-tetraphosphate

Conditions
ConditionsYield
With pyrophosphatase; L-lysine; potassium chloride; magnesium chloride In water at 37℃; for 2h; pH 8;70%

56-65-5Relevant articles and documents

Analytical Techniques for the Determination of Chemical Exchange Rate Constants with Application to the Creatine Kinase Reaction

Sorce, Dennis J.,Sciacca, Robert R.,Keller, Andrew M.

, p. 230 - 241 (1990)

A method for determining biochemical exchange rates for analysis of inversion recovery experiments is described.As used in the current application, the technique involves fitting multiexponential equations to the magnetization recovery curves for PCr and ATP.From the parameters of the exponential fits expressions for the forward and reverse rate constants are derived.Results obtained with this technique were compared with inversion transfer and with previously published results using saturation transfer.The addition of a third exchanging species was also investigated and found to have no significant effect on the calculated values for the forward and reverse rate constants.In addition, the feasibility of using an abbreviated 6-point sampling strategy was evaluated; values for the rate constants were similar to those obtained using all 21 data points.The results of this study indicate that chemical exchange rate constants can be determined using inversion recovery techniques which avoid many of the difficulties associated with selective excitation methods.

Practical Enzymatic Synthesis of Adenosine 5'-O-(3-Thiotriphosphate) (ATP-γ-S)

Abril, Obsidiana,Crans, Debbie C.,Whitesides, George M.

, p. 1360 - 1364 (1984)

An enzymatic procedure for the synthesis of adenosine 5'-O-(3-thiotriphosphate) (ATP-γ-S) on a 50-mmol scale from dihydroxyacetone, sodium thiophosphate, ADP, and phosphoenol pyruvate is described.The synthesis uses polyacrylamide gel immobilized glycerokinase coupled to a pyruvate kinase catalyzed ATP cofactor regeneration system, and polyacrylamide gel immobilized triosephosphate isomerase, glyceraldehyde 3-phosphate dehydrogenase, and phosphoglycerate kinase coupled to a lactate dehydrogenase catalyzed NAD cofactor regeneration system.The ATP-γ-S is purified by adsorption on Dowex 1 and isolated as the sodium or barium salts in ca. 90 percent purity.

Graphene oxide enhanced specificity at aptamer and its application to multiplexed enzymatic activity sensing

Xing, Xiaojing,Liu, Xueguo,Zhou, Ying,Xu, Dangdang,Pang, Daiwen,Tang, Hongwu

, p. 11815 - 11821 (2016)

We explore the effect of sufficient GO on the property of a dye labeled adenosine 5′-triphosphate (ATP) aptamer (P) which shows similar affinity and specificity for ATP and its analogues including adenosine 5′-diphosphate (ADP), adenosine 5′-monophosphate (AMP), and adenosine (AD). It is found that ATP and its analogues give rise to fluorescence recovery of GO-quenched P to a different extent (in the order of ATP > AD > ADP > AMP), and the difference becomes larger when increasing the concentration of GO in a certain range, implying an improvement of specificity of the ATP aptamer. Based on this finding, a fluorescence turn-on assay for alkaline phosphatase (ALP) and creatine kinase (CK) is proposed, by using AMP and ADP as the substrate, respectively. Specifically, the GO-quenched P system containing substrate shows low fluorescence intensity. In the presence of target enzyme, the substrate is converted into either AD or ATP which have higher affinity with P, resulting in stronger fluorescence of the mixture of P and GO. The entire assay is sensitive and selective. More importantly, the ability of GO with suitable concentration to improve the specificity of aptamers not only offers an exciting new way to detect protease, but also is valuable for developing the application of GO and aptamers in the biosensing field and is expected to be used in aptamer screening systems, to improve the specificity of screened aptamers.

Design, synthesis, and anticancer activity of phosphonic acid diphosphate derivative of adenine-containing butenolide and its water-soluble derivatives of paclitaxel with high antitumor activity

Moosavi-Movahedi, Ali A.,Hakimelahi, Shahram,Chamani, Jamshid,Khodarahmi, Ghadam Ali,Hassanzadeh, Farshid,Luo, Fen-Tair,Ly, Tai Wei,Shia, Kak-Shan,Yen, Chi-Feng,Jain, Moti L.,Kulatheeswaran, Ramasamy,Xue, Cuihua,Pasdar, Manijeh,Hakimelahi, Gholam Hossein

, p. 4303 - 4313 (2003)

Synthesis of adenine derivative of triphosphono-γ -(Z)-ethylidene-2,3-dimethoxybutenolide 4 was accomplished by treatment of phosphonate 3 with 5-phosphoribosyl 1-pyrophosphate in the presence of 5-phosphoribosyl 1-pyrophosphate synthetase. It was found that triphosphonate 4 functions as an irreversible stoichiometric inactivator of the Escherichia coli ribonucleoside diphosphate reductase (RDPR). Triphosphonate 4 exhibited potent inhibitory activity against murine leukemias (L1210 and P388), breast carcinoma (MCF7), and human T-lymphoblasts (Molt4/C8 and CEM/0) cell lines. Paclitaxel ester derivatives of adenine-containing triphosphono-γ -(Z)-ethylidene-2,3-dimethoxybutenolide 8-10 were also synthesized. Like triphosphonate 4, compound 8 exhibited inhibitory property toward RDPR. It also induced microtubule assembly similar to paclitaxel (5). The structure of the chlorodiester linker in 8 was found to account for this dual property. After treatment of MCF7 cells with compounds 4, 5, and 8, fluorescence microscope examination demonstrated the presence of nucleus shrinkage or segmentation. Bifunctional prodrug 8 exhibited higher lipophilicity than 4 and higher water-solubility than 5. Pro-dual-drug 8 exhibited more pronounced anticancer activity relative to that of the triphosphonate 4 and paclitaxel (5). In contrast, compound 9, resulting from the linkage of triphosphonate 4 and paclitaxel (5) through a diester unit, was only found to function as a highly water-soluble prodrug for paclitaxel (5). It induced microtubule assembly in vitro, but did not show inhibitory property toward RDPR. On the other hand, compound 10, an aggregate of triphosphonate 4 and paclitaxel (5), neither functioned as an inhibitor of RDPR nor exhibited microtubule assembly stimulating activity in vitro.

Conformational dynamics and allostery in pyruvate kinase

Donovan, Katherine A.,Zhu, Shaolong,Liuni, Peter,Peng, Fen,Kessans, Sarah A.,Wilson, Derek J.,Dobson, Renwick C.J.

, p. 9244 - 9256 (2016)

Pyruvate kinase catalyzes the final step in glycolysis and is allosterically regulated to control flux through the pathway. Two models are proposed to explain how Escherichia coli pyruvate kinase type 1 is allosterically regulated: the "domain rotation model" suggests that both the domains within the monomer and the monomers within the tetramer reorient with respect to one another; the "rigid body reorientation model" proposes only a reorientation of the monomers within the tetramer causing rigidification of the active site. To test these hypotheses and elucidate the conformational and dynamic changes that drive allostery, we performed time-resolved electrospray ionization mass spectrometry coupled to hydrogen-deuterium exchange studies followed by mutagenic analysis to test the activation mechanism. Global exchange experiments, supported by thermostability studies, demonstrate that fructose 1, 6-bisphosphate binding to the allosteric domain causes a shift toward a globally more dynamic ensemble of conformations. Mapping deuterium exchange to peptides within the enzyme highlight site-specific regions with altered conformational dynamics, many of which increase in conformational flexibility. Based upon these and mutagenic studies, we propose an allosteric mechanism whereby the binding of fructose 1, 6-bisphosphate destabilizes an α-helix that bridges the allosteric and active site domains within the monomeric unit This destabilizes the βstrands within the (β/α)8-barrel domain and the linked active site loops that are responsible for substrate binding. Our data are consistent with the domain rotation model but inconsistent with the rigid body reorientation model given the increased flexibility at the interdomain interface, and we can for the first time explain how fructose 1, 6-bisphosphate affects the active site.

Formation of ATP by photochemical excitation of benzoquinones in dimethylacetamide solution

Lee, Hung-Wen,Huang, Kunpo

, p. 961 - 963 (2002)

A new method of adenosine triphosphate production is described which involves photo-excitation of p-benzoquinones under the presence of adenosine diphosphate and inorganic phosphate in N,N-dimethylacetamide solution. A possible mechanism for the reaction is presented.

Physiological and biochemical characterization of three nucleoside diphosphate kinase isozymes from rice (Oryza sativa L.)

Kihara, Akihiko,Saburi, Wataru,Wakuta, Shinji,Kim, Myung-Hee,Hamada, Shigeki,Ito, Hiroyuki,Imai, Ryozo,Matsui, Hirokazu

, p. 1740 - 1745 (2011)

Nucleoside diphosphate kinase (NDPK) is a ubiquitous enzyme that catalyzes the transfer of the γ-phosphoryl group from a nucleoside triphosphate to a nucleoside diphosphate. In this study, we examined the subcellular localization, tissue-specific gene expression, and enzymatic characteristics of three rice NDPK isozymes (OsNDPK1-OsNDPK3). Sequence comparison of the three OsNDPKs suggested differential subcellular localization. Transient expression of green fluorescence protein-fused proteins in onion cells indicated that OsNDPK2 and OsNDPK3 are localized to plastid and mitochondria respectively, while OsNDPK1 is localized to the cytosol. Expression analysis indicated that all the OsNDPKs are expressed in the leaf, leaf sheath, and immature seeds, except for OsNDPK1, in the leaf sheath. Recombinant OsNDPK2 and OsNDPK3 showed lower optimum pH and higher stability under acidic pH than OsNDPK1. In ATP formation, all the OsNDPKs displayed lower Km values for the second substrate, ADP, than for the first substrate, NTP, and showed lowest and highest K m values for GTP and CTP respectively.

Biomimetic One-Pot Synthesis of Nucleotide Phosphates

Tabushi, Iwao,Imuta, Jun-ichi

, p. 5415 - 5418 (1982)

A strongly hydrophobic rigid diammonium, 1, an efficient extracting and transporting phase transfer reagent with high specificity for the pyrophosphate grouping, was used to synthesize ADP, ATP or ADP-NH2 in a hydrophobic medium.Thus, practically pure ADP-NH2 was obtained in 65 percent yield within 2 min.

Functional analysis, overexpression, and kinetic characterization of pyruvate kinase from methicillin-resistant staphylococcus aureus

Zoraghi, Roya,See, Raymond H.,Gong, Huansheng,Lian, Tian,Swayze, Rick,Finlay, B. Brett,Brunham, Robert C.,McMaster, William R.,Reiner, Neil E.

, p. 7733 - 7747 (2010)

Novel antimicrobial targets are urgently needed to overcome rising antibiotic resistance of important human pathogens including methicillin-resistant Staphylococcus aureus (MRSA). Here we report the essentiality and kinetic properties of MRSA pyruvate kinase (PK). Targetron-mediated gene disruption demonstrated PK is essential for S. aureus growth and survival, suggesting that this protein may be a potential drug target. The presence of the pfk (6-phosphofructokinase)-pyk operon in MRSA252, and the nonessential nature of PFK shown by targetron, further emphasized the essential role of PK in cell viability. The importance of PK in bacterial growth was confirmed by showing that its enzymatic activity peaked during the logarithmic phase of S. aureus growth. PK from Staphylococcus and several other species of bacteria have an extra C-terminal domain (CT) containing a phosphoenolpyruvate (PEP) binding motif. To elucidate the possible structure and function of this sequence, the quaternary structures and kinetic properties of the full-length MRSA PK and truncated MRSA PK lacking the CT domain were characterized. Our results showed that (1) MRSA PK is an allosteric enzyme with homotetramer architecture activated by AMP or ribose 5-phosphate (R5P), but not by fructose 1,6-bisphosphate (FBP), which suggests a different mode of allosteric regulation when compared with human isozymes, (2) the CT domain is not required for the tetramerization of the enzyme; homotetramerization occurred in a truncated PK lacking the domain, (3) truncated enzyme exhibited high affinity toward both PEP and ADP and exhibited hyperbolic kinetics toward PEP in the presence of activators (AMP and R5P) consistent with kinetic properties of full-length enzyme, indicating that the CT domain is not required for substrate binding or allosteric regulation observed in the holoenzyme, (4) the kinetic efficiency (kcat/S0.5) of truncated enzyme was decreased by 24- and 16-fold, in ligand-free state, toward PEP and ADP, respectively, but was restored by 3-fold in AMP-bound state, suggesting that the sequence containing the CT domain (Gly473-Leu585) plays a substantial role in enzyme activity and comformational stability, and (5) full-length MRSA PK activity was stimulated at low concentrations of ATP (e.g., 1 mM) and inhibited by inorganic phosphate and high concentrations of FBP (10 mM) and ATP (e.g., >2.5 mM), whereas for truncated enzyme, stimulation at low concentrations of ATP was lost. These findings suggest that the CT domain is involved in maintaining the specificity of allosteric regulation of MRSA PK by AMP, R5P, and ATP. The CT extension also encodes a protein domain with homology to enzyme I of the Escherichia coli sugar-PTS system, suggesting that MRSA PK may also exert an important regulatory role in sugar transport metabolism. These findings yield new insights into MRSA PK function and mode of allosteric regulation which may aid in the development of clinically important drugs targeting this enzyme and further define the role of the extra C-terminal domain in modulating the enzyme's activity.

STOICHIOMETRY OF PROTON TRANSLOCATION DURING PHOTOSYNTHESIS.

Rathenow,Rumberg

, p. 1059 - 1062 (1980)

Formation of ATP in photosynthesis takes place at the expense of free energy stored in the gradient of protons across the thylakoid membrane. Set up of the proton gradient is accomplished by the light-driven electron transport reactions. The stoichiometry of H** plus translocation across the thylakoid membrane is determined with respect to electron flow and ATP synthesis. Direct information is obtained on the basis of the H** plus flux measurement. Depending on the experimental conditions two or three H** plus are translocated from outside into the aqueous inner phase of the thylakoid vesicles for each electron which is transfered through the electron transport chain. Three H** plus are translocated from inside to outside across the ATPase for each ATP molecule which is synthesized. Mechanistic and energetic consequences are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 56-65-5